Home LiteratureArticle Details
PMID: 17005698 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Murine model for dengue virus-induced lethal disease with increased vascular permeability.

Journal of virology ·Vol. 80 ·No. 20 ·2006-10-00 ·Pages 10208-17

Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E

Abstract

Lack of an appropriate animal model for dengue virus (DEN), which causes dengue fever and dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), has impeded characterization of the mechanisms underlying the disease pathogenesis. The cardinal feature of DHF/DSS, the severe form of DEN infection, is increased vascular permeability. To develop a murine model that is more relevant to DHF/DSS, a novel DEN strain, D2S10, was generated by alternately passaging a non-mouse-adapted DEN strain between mosquito cells and mice, thereby mimicking the natural transmission cycle of the virus between mosquitoes and humans. After infection with D2S10, mice lacking interferon receptors died early without manifesting signs of paralysis, carried infectious virus in both non-neuronal and neuronal tissues, and exhibited signs of increased vascular permeability. In contrast, mice infected with the parental DEN strain developed paralysis at late times after infection, contained detectable levels of virus only in the central nervous system, and displayed normal vascular permeability. In the mice infected with D2S10, but not the parental DEN strain, significant levels of serum tumor necrosis factor alpha (TNF-alpha) were produced, and the neutralization of TNF-alpha activity prevented early death of D2S10-infected mice. Sequence analysis comparing D2S10 to its parental strain implicated a conserved region of amino acid residues in the envelope protein as a possible source for the D2S10 phenotype. These results demonstrate that D2S10 causes a more relevant disease in mice and that TNF-alpha may be one of several key mediators of severe DEN-induced disease in mice. This report represents a significant advance in animal models for severe DEN disease, and it begins to provide mechanistic insights into DEN-induced disease in vivo.

MeSH Terms
Amino Acid Substitution Animals Capillary Permeability Conserved Sequence Dengue Virus/genetics,growth & development,pathogenicity Disease Models, Animal Histocytochemistry Mice Mice, Knockout Mutation, Missense Receptors, Interferon/genetics Sequence Analysis, DNA Severe Dengue/pathology,physiopathology Survival Analysis Tumor Necrosis Factor-alpha/analysis,antagonists & inhibitors Viral Envelope Proteins/genetics Viral Plaque Assay
Chemicals
Receptors, Interferon Tumor Necrosis Factor-alpha Viral Envelope Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Shresta Sujan
Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. sujan@liai.org
Sharar Kristin L
Prigozhin Daniil M
Beatty P Robert
Harris Eva
References (38)
38 references, click to expand
  1. Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection.
    FEMS Immunol Med Microbiol. 2003 Jan 21;35(1):33-42 PMID: 12589955
  2. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population.
    Nature. 2006 Jan 19;439(7074):344-8 PMID: 16327776
  3. A ligand-binding pocket in the dengue virus envelope glycoprotein.
    Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6986-91 PMID: 12759475
  4. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.
    Nat Med. 2003 Jul;9(7):921-7 PMID: 12808447
  5. Immunology and immunopathogenesis of dengue disease.
    Adv Virus Res. 2003;60:397-419 PMID: 14689699
  6. Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice.
    Virology. 2004 Feb 20;319(2):262-73 PMID: 14980486
  7. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical.
    J Virol. 2004 Mar;78(6):2701-10 PMID: 14990690
  8. Analysis of recombinant dengue virus polypeptides for dengue diagnosis and evaluation of the humoral immune response.
    Am J Trop Med Hyg. 2004 Aug;71(2):144-52 PMID: 15306702
  9. Antibody-enhanced dengue virus infection in primate leukocytes.
    Nature. 1977 Feb 24;265(5596):739-41 PMID: 404559
  10. Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants.
    Infect Immun. 1982 Jun;36(3):1036-41 PMID: 6284641
  11. Pathogenesis of dengue: challenges to molecular biology.
    Science. 1988 Jan 29;239(4839):476-81 PMID: 3277268
  12. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients.
    Am J Trop Med Hyg. 1993 Mar;48(3):324-31 PMID: 8470771
  13. Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection.
    Am J Trop Med Hyg. 1995 May;52(5):468-76 PMID: 7771614
  14. Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984-1994.
    Am J Trop Med Hyg. 1998 Aug;59(2):265-71 PMID: 9715944
  15. Study of Dengue virus infection in SCID mice engrafted with human K562 cells.
    J Virol. 1998 Dec;72(12):9729-37 PMID: 9811707
  16. New mouse model for dengue virus vaccine testing.
    J Virol. 1999 Jan;73(1):783-6 PMID: 9847388
  17. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity.
    J Infect Dis. 1999 Apr;179(4):755-62 PMID: 10068569
  18. Immunopathogenesis of Dengue hemorrhagic fever.
    Virology. 1999 Apr 25;257(1):1-6 PMID: 10208914
  19. Dengue virus structural differences that correlate with pathogenesis.
    J Virol. 1999 Jun;73(6):4738-47 PMID: 10233934
  20. Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia.
    J Exp Med. 2004 Dec 6;200(11):1395-405 PMID: 15583013
  21. A structural perspective of the flavivirus life cycle.
    Nat Rev Microbiol. 2005 Jan;3(1):13-22 PMID: 15608696
  22. Selection for virulent dengue viruses occurs in humans and mosquitoes.
    J Virol. 2005 Jan;79(2):853-9 PMID: 15613313
  23. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein.
    J Virol. 2005 Jan;79(2):1223-31 PMID: 15613349
  24. Role of RNA structures present at the 3'UTR of dengue virus on translation, RNA synthesis, and viral replication.
    Virology. 2005 Sep 1;339(2):200-12 PMID: 16002117
  25. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice.
    J Immunol. 2005 Sep 15;175(6):3946-54 PMID: 16148142
  26. Dengue fever in humanized NOD/SCID mice.
    J Virol. 2005 Nov;79(21):13797-9 PMID: 16227299
  27. Development of a novel mouse model for dengue virus infection.
    Virology. 1999 Oct 10;263(1):70-7 PMID: 10544083
  28. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.
    J Infect Dis. 2000 Jan;181(1):2-9 PMID: 10608744
  29. Neurological manifestations of dengue infection.
    Lancet. 2000 Mar 25;355(9209):1053-9 PMID: 10744091
  30. Manifestation of thrombocytopenia in dengue-2-virus-infected mice.
    J Gen Virol. 2000 Sep;81(Pt 9):2177-82 PMID: 10950974
  31. Determination of tumor necrosis factor-alpha levels in dengue virus infected patients by sensitive biotin-streptavidin enzyme-linked immunosorbent assay.
    J Virol Methods. 2000 Oct;90(1):51-7 PMID: 11011080
  32. Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies.
    J Infect Dis. 2001 May 15;183(10):1431-6 PMID: 11319679
  33. Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology.
    J Infect Dis. 2001 May 15;183(10):1437-44 PMID: 11319680
  34. Immunopathogenesis of dengue virus infection.
    J Biomed Sci. 2001 Sep;8(5):377-88 PMID: 11549879
  35. Molecular characterization of a hamster viscerotropic strain of yellow fever virus.
    J Virol. 2003 Jan;77(2):1462-8 PMID: 12502861
  36. A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys.
    J Virol. 2003 Jan;77(2):1653-7 PMID: 12502885
  37. Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3' stem-loop structure.
    Virology. 2006 Jan 20;344(2):439-52 PMID: 16214197
  38. American genotype structures decrease dengue virus output from human monocytes and dendritic cells.
    J Virol. 2003 Apr;77(7):3929-38 PMID: 12634353
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2006-10-00
Pages
10208-17
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC1617308
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com